While IL-22 has been implicated in psoriasis [10], [37], [38], [39], a benign hyperproliferative keratinocyte disease that shares gene expression patterns with SCC [40], mounting evidence suggests that IL-22 may also be implicated in malignant processes. The gene discussed is IL22; the disease is psoriasis.